nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—GNRHR—Peptide GPCRs—CCR3—atopic dermatitis	0.0087	0.0608	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CXCR3—atopic dermatitis	0.0076	0.0531	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CXCR3—atopic dermatitis	0.00645	0.045	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00522	0.0365	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCR5—atopic dermatitis	0.00477	0.0333	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00466	0.0325	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00418	0.0292	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CCR5—atopic dermatitis	0.00404	0.0282	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL22—atopic dermatitis	0.00398	0.0278	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00369	0.0258	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—NPS—atopic dermatitis	0.00369	0.0258	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL27—atopic dermatitis	0.00355	0.0248	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00337	0.0235	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.0033	0.0231	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.0033	0.0231	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL17—atopic dermatitis	0.00318	0.0222	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00274	0.0192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL11—atopic dermatitis	0.00256	0.0179	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00245	0.0171	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00245	0.0171	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0024	0.0168	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR3—atopic dermatitis	0.00209	0.0146	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL22—atopic dermatitis	0.00204	0.0143	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCL27—atopic dermatitis	0.002	0.014	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00194	0.0136	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—TAC1—atopic dermatitis	0.00186	0.013	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPS—atopic dermatitis	0.00186	0.013	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCR3—atopic dermatitis	0.00183	0.0128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL27—atopic dermatitis	0.00182	0.0127	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00167	0.0117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL17—atopic dermatitis	0.00163	0.0114	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.0015	0.0105	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL10—atopic dermatitis	0.00148	0.0103	CbGpPWpGaD
Nafarelin—Affect lability—Dexamethasone—atopic dermatitis	0.00142	0.00165	CcSEcCtD
Nafarelin—Convulsion—Tacrolimus—atopic dermatitis	0.00141	0.00165	CcSEcCtD
Nafarelin—Muscular weakness—Triamcinolone—atopic dermatitis	0.0014	0.00163	CcSEcCtD
Nafarelin—Muscular weakness—Methylprednisolone—atopic dermatitis	0.0014	0.00163	CcSEcCtD
Nafarelin—Asthenia—Loratadine—atopic dermatitis	0.00139	0.00163	CcSEcCtD
Nafarelin—Myalgia—Tacrolimus—atopic dermatitis	0.00139	0.00162	CcSEcCtD
Nafarelin—Chest pain—Tacrolimus—atopic dermatitis	0.00139	0.00162	CcSEcCtD
Nafarelin—Arthralgia—Tacrolimus—atopic dermatitis	0.00139	0.00162	CcSEcCtD
Nafarelin—Abdominal distension—Triamcinolone—atopic dermatitis	0.00138	0.00161	CcSEcCtD
Nafarelin—Abdominal distension—Methylprednisolone—atopic dermatitis	0.00138	0.00161	CcSEcCtD
Nafarelin—Mood swings—Betamethasone—atopic dermatitis	0.00136	0.00159	CcSEcCtD
Nafarelin—Mood swings—Dexamethasone—atopic dermatitis	0.00136	0.00159	CcSEcCtD
Nafarelin—Weight increased—Prednisolone—atopic dermatitis	0.00136	0.00158	CcSEcCtD
Nafarelin—Sweating increased—Triamcinolone—atopic dermatitis	0.00134	0.00156	CcSEcCtD
Nafarelin—Increased appetite—Prednisone—atopic dermatitis	0.00133	0.00156	CcSEcCtD
Nafarelin—Sweating increased—Methylprednisolone—atopic dermatitis	0.00133	0.00156	CcSEcCtD
Nafarelin—Diarrhoea—Loratadine—atopic dermatitis	0.00133	0.00155	CcSEcCtD
Nafarelin—Oedema—Tacrolimus—atopic dermatitis	0.00133	0.00155	CcSEcCtD
Nafarelin—Weight increased—Hydrocortisone—atopic dermatitis	0.00133	0.00155	CcSEcCtD
Nafarelin—Dry skin—Betamethasone—atopic dermatitis	0.00132	0.00154	CcSEcCtD
Nafarelin—Dry skin—Dexamethasone—atopic dermatitis	0.00132	0.00154	CcSEcCtD
Nafarelin—Weight decreased—Hydrocortisone—atopic dermatitis	0.00132	0.00154	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL11—atopic dermatitis	0.00132	0.0092	CbGpPWpGaD
Nafarelin—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.00131	0.00153	CcSEcCtD
Nafarelin—Shock—Tacrolimus—atopic dermatitis	0.00131	0.00152	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisolone—atopic dermatitis	0.0013	0.00152	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—FCER2—atopic dermatitis	0.0013	0.00907	CbGpPWpGaD
Nafarelin—Conjunctivitis—Prednisolone—atopic dermatitis	0.00129	0.00151	CcSEcCtD
Nafarelin—Dizziness—Loratadine—atopic dermatitis	0.00129	0.0015	CcSEcCtD
Nafarelin—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00128	0.0015	CcSEcCtD
Nafarelin—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00128	0.00149	CcSEcCtD
Nafarelin—Myocardial infarction—Hydrocortisone—atopic dermatitis	0.00127	0.00149	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL5—atopic dermatitis	0.00127	0.00888	CbGpPWpGaD
Nafarelin—Muscular weakness—Betamethasone—atopic dermatitis	0.00127	0.00148	CcSEcCtD
Nafarelin—Muscular weakness—Dexamethasone—atopic dermatitis	0.00127	0.00148	CcSEcCtD
Nafarelin—Anorexia—Tacrolimus—atopic dermatitis	0.00127	0.00148	CcSEcCtD
Nafarelin—Weight increased—Triamcinolone—atopic dermatitis	0.00125	0.00146	CcSEcCtD
Nafarelin—Weight increased—Methylprednisolone—atopic dermatitis	0.00125	0.00145	CcSEcCtD
Nafarelin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00124	0.00144	CcSEcCtD
Nafarelin—Vomiting—Loratadine—atopic dermatitis	0.00124	0.00144	CcSEcCtD
Nafarelin—Affect lability—Prednisone—atopic dermatitis	0.00123	0.00144	CcSEcCtD
Nafarelin—Rash—Loratadine—atopic dermatitis	0.00123	0.00143	CcSEcCtD
Nafarelin—Dermatitis—Loratadine—atopic dermatitis	0.00122	0.00143	CcSEcCtD
Nafarelin—Headache—Loratadine—atopic dermatitis	0.00122	0.00142	CcSEcCtD
Nafarelin—Sweating increased—Dexamethasone—atopic dermatitis	0.00121	0.00141	CcSEcCtD
Nafarelin—Sweating increased—Betamethasone—atopic dermatitis	0.00121	0.00141	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00121	0.00141	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL22—atopic dermatitis	0.00121	0.00843	CbGpPWpGaD
Nafarelin—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.00121	0.00141	CcSEcCtD
Nafarelin—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Insomnia—Tacrolimus—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Myocardial infarction—Triamcinolone—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Asthenia—Mometasone—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Myocardial infarction—Methylprednisolone—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.0014	CcSEcCtD
Nafarelin—Paraesthesia—Tacrolimus—atopic dermatitis	0.00119	0.00139	CcSEcCtD
Nafarelin—Conjunctivitis—Triamcinolone—atopic dermatitis	0.00119	0.00139	CcSEcCtD
Nafarelin—Mood swings—Prednisone—atopic dermatitis	0.00119	0.00139	CcSEcCtD
Nafarelin—Dyspnoea—Tacrolimus—atopic dermatitis	0.00118	0.00138	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR3—atopic dermatitis	0.00118	0.00825	CbGpPWpGaD
Nafarelin—Pruritus—Mometasone—atopic dermatitis	0.00118	0.00138	CcSEcCtD
Nafarelin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00116	0.00135	CcSEcCtD
Nafarelin—Nausea—Loratadine—atopic dermatitis	0.00115	0.00135	CcSEcCtD
Nafarelin—Decreased appetite—Tacrolimus—atopic dermatitis	0.00115	0.00135	CcSEcCtD
Nafarelin—Epistaxis—Triamcinolone—atopic dermatitis	0.00115	0.00135	CcSEcCtD
Nafarelin—Dry skin—Prednisone—atopic dermatitis	0.00115	0.00134	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—atopic dermatitis	0.00115	0.008	CbGpPWpGaD
Nafarelin—Diarrhoea—Mometasone—atopic dermatitis	0.00114	0.00133	CcSEcCtD
Nafarelin—Constipation—Tacrolimus—atopic dermatitis	0.00114	0.00133	CcSEcCtD
Nafarelin—Weight increased—Betamethasone—atopic dermatitis	0.00113	0.00132	CcSEcCtD
Nafarelin—Weight increased—Dexamethasone—atopic dermatitis	0.00113	0.00132	CcSEcCtD
Nafarelin—Weight decreased—Betamethasone—atopic dermatitis	0.00113	0.00131	CcSEcCtD
Nafarelin—Weight decreased—Dexamethasone—atopic dermatitis	0.00113	0.00131	CcSEcCtD
Nafarelin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00111	0.0013	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—atopic dermatitis	0.00111	0.00129	CcSEcCtD
Nafarelin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.0011	0.00129	CcSEcCtD
Nafarelin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.0011	0.00128	CcSEcCtD
Nafarelin—Rhinitis—Triamcinolone—atopic dermatitis	0.0011	0.00128	CcSEcCtD
Nafarelin—Rhinitis—Methylprednisolone—atopic dermatitis	0.0011	0.00128	CcSEcCtD
Nafarelin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00109	0.00128	CcSEcCtD
Nafarelin—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.00109	0.00128	CcSEcCtD
Nafarelin—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.00109	0.00128	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—atopic dermatitis	0.00109	0.00127	CcSEcCtD
Nafarelin—Myocardial infarction—Dexamethasone—atopic dermatitis	0.00109	0.00127	CcSEcCtD
Nafarelin—Myocardial infarction—Betamethasone—atopic dermatitis	0.00109	0.00127	CcSEcCtD
Nafarelin—Conjunctivitis—Dexamethasone—atopic dermatitis	0.00108	0.00126	CcSEcCtD
Nafarelin—Conjunctivitis—Betamethasone—atopic dermatitis	0.00108	0.00126	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL27—atopic dermatitis	0.00108	0.00751	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR3—atopic dermatitis	0.00107	0.0075	CbGpPWpGaD
Nafarelin—Vomiting—Mometasone—atopic dermatitis	0.00106	0.00124	CcSEcCtD
Nafarelin—Sweating increased—Prednisone—atopic dermatitis	0.00106	0.00123	CcSEcCtD
Nafarelin—Urticaria—Tacrolimus—atopic dermatitis	0.00105	0.00123	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—NPS—atopic dermatitis	0.00105	0.00736	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—TAC1—atopic dermatitis	0.00105	0.00736	CbGpPWpGaD
Nafarelin—Rash—Mometasone—atopic dermatitis	0.00105	0.00123	CcSEcCtD
Nafarelin—Dermatitis—Mometasone—atopic dermatitis	0.00105	0.00123	CcSEcCtD
Nafarelin—Headache—Mometasone—atopic dermatitis	0.00105	0.00122	CcSEcCtD
Nafarelin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00104	0.00121	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00103	0.00722	CbGpPWpGaD
Nafarelin—Mental disorder—Hydrocortisone—atopic dermatitis	0.00102	0.00119	CcSEcCtD
Nafarelin—Malnutrition—Hydrocortisone—atopic dermatitis	0.00102	0.00118	CcSEcCtD
Nafarelin—Nausea—Mometasone—atopic dermatitis	0.000991	0.00116	CcSEcCtD
Nafarelin—Weight increased—Prednisone—atopic dermatitis	0.000986	0.00115	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—atopic dermatitis	0.000981	0.00114	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—IL5—atopic dermatitis	0.000979	0.00684	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL17—atopic dermatitis	0.000964	0.00674	CbGpPWpGaD
Nafarelin—Depression—Prednisone—atopic dermatitis	0.000964	0.00112	CcSEcCtD
Nafarelin—Mental disorder—Methylprednisolone—atopic dermatitis	0.00096	0.00112	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—NPS—atopic dermatitis	0.000956	0.00668	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TAC1—atopic dermatitis	0.000956	0.00668	CbGpPWpGaD
Nafarelin—Malnutrition—Methylprednisolone—atopic dermatitis	0.000954	0.00111	CcSEcCtD
Nafarelin—Asthenia—Tacrolimus—atopic dermatitis	0.000953	0.00111	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000953	0.00111	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—atopic dermatitis	0.000947	0.00111	CcSEcCtD
Nafarelin—Pruritus—Tacrolimus—atopic dermatitis	0.00094	0.0011	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000938	0.00655	CbGpPWpGaD
Nafarelin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000936	0.00109	CcSEcCtD
Nafarelin—Vertigo—Prednisolone—atopic dermatitis	0.000934	0.00109	CcSEcCtD
Nafarelin—Vertigo—Hydrocortisone—atopic dermatitis	0.000912	0.00106	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000909	0.00635	CbGpPWpGaD
Nafarelin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000909	0.00106	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—atopic dermatitis	0.0009	0.00105	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—IL5—atopic dermatitis	0.000889	0.00621	CbGpPWpGaD
Nafarelin—Alopecia—Dexamethasone—atopic dermatitis	0.00088	0.00103	CcSEcCtD
Nafarelin—Alopecia—Betamethasone—atopic dermatitis	0.00088	0.00103	CcSEcCtD
Nafarelin—Convulsion—Hydrocortisone—atopic dermatitis	0.000879	0.00103	CcSEcCtD
Nafarelin—Dizziness—Tacrolimus—atopic dermatitis	0.000878	0.00102	CcSEcCtD
Nafarelin—Myalgia—Hydrocortisone—atopic dermatitis	0.000864	0.00101	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—KIF3A—atopic dermatitis	0.000859	0.00601	CbGpPWpGaD
Nafarelin—Vertigo—Triamcinolone—atopic dermatitis	0.000859	0.001	CcSEcCtD
Nafarelin—Vertigo—Methylprednisolone—atopic dermatitis	0.000857	0.001	CcSEcCtD
Nafarelin—Oedema—Prednisolone—atopic dermatitis	0.000848	0.00099	CcSEcCtD
Nafarelin—Vomiting—Tacrolimus—atopic dermatitis	0.000844	0.000985	CcSEcCtD
Nafarelin—Rash—Tacrolimus—atopic dermatitis	0.000837	0.000977	CcSEcCtD
Nafarelin—Dermatitis—Tacrolimus—atopic dermatitis	0.000837	0.000976	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000834	0.00583	CbGpPWpGaD
Nafarelin—Shock—Prednisolone—atopic dermatitis	0.000834	0.000974	CcSEcCtD
Nafarelin—Headache—Tacrolimus—atopic dermatitis	0.000832	0.000971	CcSEcCtD
Nafarelin—Oedema—Hydrocortisone—atopic dermatitis	0.000828	0.000967	CcSEcCtD
Nafarelin—Convulsion—Triamcinolone—atopic dermatitis	0.000828	0.000966	CcSEcCtD
Nafarelin—Convulsion—Methylprednisolone—atopic dermatitis	0.000826	0.000964	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00082	0.000957	CcSEcCtD
Nafarelin—Shock—Hydrocortisone—atopic dermatitis	0.000815	0.000951	CcSEcCtD
Nafarelin—Myalgia—Triamcinolone—atopic dermatitis	0.000814	0.00095	CcSEcCtD
Nafarelin—Myalgia—Methylprednisolone—atopic dermatitis	0.000812	0.000947	CcSEcCtD
Nafarelin—Arthralgia—Methylprednisolone—atopic dermatitis	0.000812	0.000947	CcSEcCtD
Nafarelin—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000801	0.000935	CcSEcCtD
Nafarelin—Anorexia—Hydrocortisone—atopic dermatitis	0.00079	0.000921	CcSEcCtD
Nafarelin—Nausea—Tacrolimus—atopic dermatitis	0.000789	0.00092	CcSEcCtD
Nafarelin—Oedema—Triamcinolone—atopic dermatitis	0.00078	0.00091	CcSEcCtD
Nafarelin—Vertigo—Betamethasone—atopic dermatitis	0.000779	0.000909	CcSEcCtD
Nafarelin—Vertigo—Dexamethasone—atopic dermatitis	0.000779	0.000909	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL11—atopic dermatitis	0.000777	0.00543	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CMA1—atopic dermatitis	0.000777	0.00543	CbGpPWpGaD
Nafarelin—Shock—Triamcinolone—atopic dermatitis	0.000767	0.000896	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—atopic dermatitis	0.000767	0.000895	CcSEcCtD
Nafarelin—Alopecia—Prednisone—atopic dermatitis	0.000767	0.000895	CcSEcCtD
Nafarelin—Shock—Methylprednisolone—atopic dermatitis	0.000766	0.000894	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—atopic dermatitis	0.000762	0.000889	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—atopic dermatitis	0.00076	0.000887	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000758	0.0053	CbGpPWpGaD
Nafarelin—Malnutrition—Prednisone—atopic dermatitis	0.000755	0.000881	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000755	0.000881	CcSEcCtD
Nafarelin—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000754	0.00088	CcSEcCtD
Nafarelin—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000752	0.000878	CcSEcCtD
Nafarelin—Convulsion—Betamethasone—atopic dermatitis	0.000751	0.000877	CcSEcCtD
Nafarelin—Convulsion—Dexamethasone—atopic dermatitis	0.000751	0.000877	CcSEcCtD
Nafarelin—Insomnia—Hydrocortisone—atopic dermatitis	0.000749	0.000874	CcSEcCtD
Nafarelin—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000744	0.000868	CcSEcCtD
Nafarelin—Myalgia—Betamethasone—atopic dermatitis	0.000738	0.000862	CcSEcCtD
Nafarelin—Myalgia—Dexamethasone—atopic dermatitis	0.000738	0.000862	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—STAT6—atopic dermatitis	0.000731	0.00511	CbGpPWpGaD
Nafarelin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.00072	0.00084	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000718	0.00502	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000711	0.000829	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000709	0.000827	CcSEcCtD
Nafarelin—Oedema—Dexamethasone—atopic dermatitis	0.000708	0.000826	CcSEcCtD
Nafarelin—Oedema—Betamethasone—atopic dermatitis	0.000708	0.000826	CcSEcCtD
Nafarelin—Insomnia—Triamcinolone—atopic dermatitis	0.000705	0.000823	CcSEcCtD
Nafarelin—Insomnia—Methylprednisolone—atopic dermatitis	0.000704	0.000821	CcSEcCtD
Nafarelin—Paraesthesia—Triamcinolone—atopic dermatitis	0.0007	0.000817	CcSEcCtD
Nafarelin—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000699	0.000816	CcSEcCtD
Nafarelin—Shock—Dexamethasone—atopic dermatitis	0.000696	0.000813	CcSEcCtD
Nafarelin—Shock—Betamethasone—atopic dermatitis	0.000696	0.000813	CcSEcCtD
Nafarelin—Dyspnoea—Triamcinolone—atopic dermatitis	0.000695	0.000812	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000692	0.00484	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.00069	0.00482	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000684	0.000798	CcSEcCtD
Nafarelin—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000684	0.000798	CcSEcCtD
Nafarelin—Vertigo—Prednisone—atopic dermatitis	0.000679	0.000792	CcSEcCtD
Nafarelin—Anorexia—Dexamethasone—atopic dermatitis	0.000675	0.000787	CcSEcCtD
Nafarelin—Anorexia—Betamethasone—atopic dermatitis	0.000675	0.000787	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—atopic dermatitis	0.000674	0.000786	CcSEcCtD
Nafarelin—Urticaria—Hydrocortisone—atopic dermatitis	0.000658	0.000768	CcSEcCtD
Nafarelin—Convulsion—Prednisone—atopic dermatitis	0.000654	0.000764	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL5—atopic dermatitis	0.000652	0.00456	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000647	0.00452	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000645	0.000752	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000645	0.000752	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—atopic dermatitis	0.000643	0.00075	CcSEcCtD
Nafarelin—Myalgia—Prednisone—atopic dermatitis	0.000643	0.00075	CcSEcCtD
Nafarelin—Insomnia—Dexamethasone—atopic dermatitis	0.00064	0.000747	CcSEcCtD
Nafarelin—Insomnia—Betamethasone—atopic dermatitis	0.00064	0.000747	CcSEcCtD
Nafarelin—Paraesthesia—Dexamethasone—atopic dermatitis	0.000636	0.000742	CcSEcCtD
Nafarelin—Paraesthesia—Betamethasone—atopic dermatitis	0.000636	0.000742	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR3—atopic dermatitis	0.000634	0.00443	CbGpPWpGaD
Nafarelin—Urticaria—Triamcinolone—atopic dermatitis	0.00062	0.000723	CcSEcCtD
Nafarelin—Urticaria—Methylprednisolone—atopic dermatitis	0.000618	0.000722	CcSEcCtD
Nafarelin—Oedema—Prednisone—atopic dermatitis	0.000616	0.000719	CcSEcCtD
Nafarelin—Decreased appetite—Betamethasone—atopic dermatitis	0.000615	0.000718	CcSEcCtD
Nafarelin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000615	0.000718	CcSEcCtD
Nafarelin—Shock—Prednisone—atopic dermatitis	0.000606	0.000708	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—atopic dermatitis	0.000596	0.000695	CcSEcCtD
Nafarelin—Asthenia—Hydrocortisone—atopic dermatitis	0.000594	0.000694	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—atopic dermatitis	0.000588	0.00411	CbGpPWpGaD
Nafarelin—Anorexia—Prednisone—atopic dermatitis	0.000588	0.000686	CcSEcCtD
Nafarelin—Pruritus—Hydrocortisone—atopic dermatitis	0.000586	0.000684	CcSEcCtD
Nafarelin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000567	0.000661	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—TAC1—atopic dermatitis	0.000565	0.00395	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPS—atopic dermatitis	0.000565	0.00395	CbGpPWpGaD
Nafarelin—Urticaria—Dexamethasone—atopic dermatitis	0.000562	0.000656	CcSEcCtD
Nafarelin—Urticaria—Betamethasone—atopic dermatitis	0.000562	0.000656	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000562	0.000655	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—atopic dermatitis	0.000561	0.000655	CcSEcCtD
Nafarelin—Asthenia—Triamcinolone—atopic dermatitis	0.00056	0.000653	CcSEcCtD
Nafarelin—Asthenia—Methylprednisolone—atopic dermatitis	0.000558	0.000652	CcSEcCtD
Nafarelin—Insomnia—Prednisone—atopic dermatitis	0.000557	0.000651	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CXCR3—atopic dermatitis	0.000554	0.00387	CbGpPWpGaD
Nafarelin—Paraesthesia—Prednisone—atopic dermatitis	0.000553	0.000646	CcSEcCtD
Nafarelin—Pruritus—Triamcinolone—atopic dermatitis	0.000552	0.000644	CcSEcCtD
Nafarelin—Pruritus—Methylprednisolone—atopic dermatitis	0.000551	0.000643	CcSEcCtD
Nafarelin—Dizziness—Hydrocortisone—atopic dermatitis	0.000548	0.000639	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—atopic dermatitis	0.000536	0.000625	CcSEcCtD
Nafarelin—Rash—Prednisolone—atopic dermatitis	0.000535	0.000624	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—atopic dermatitis	0.000534	0.000624	CcSEcCtD
Nafarelin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000533	0.000621	CcSEcCtD
Nafarelin—Headache—Prednisolone—atopic dermatitis	0.000531	0.00062	CcSEcCtD
Nafarelin—Constipation—Prednisone—atopic dermatitis	0.000527	0.000615	CcSEcCtD
Nafarelin—Vomiting—Hydrocortisone—atopic dermatitis	0.000527	0.000615	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—IL5—atopic dermatitis	0.000525	0.00367	CbGpPWpGaD
Nafarelin—Rash—Hydrocortisone—atopic dermatitis	0.000522	0.00061	CcSEcCtD
Nafarelin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000522	0.000609	CcSEcCtD
Nafarelin—Headache—Hydrocortisone—atopic dermatitis	0.000519	0.000606	CcSEcCtD
Nafarelin—Dizziness—Triamcinolone—atopic dermatitis	0.000516	0.000602	CcSEcCtD
Nafarelin—Dizziness—Methylprednisolone—atopic dermatitis	0.000515	0.000601	CcSEcCtD
Nafarelin—Asthenia—Dexamethasone—atopic dermatitis	0.000508	0.000593	CcSEcCtD
Nafarelin—Asthenia—Betamethasone—atopic dermatitis	0.000508	0.000593	CcSEcCtD
Nafarelin—Nausea—Prednisolone—atopic dermatitis	0.000504	0.000588	CcSEcCtD
Nafarelin—Pruritus—Betamethasone—atopic dermatitis	0.000501	0.000584	CcSEcCtD
Nafarelin—Pruritus—Dexamethasone—atopic dermatitis	0.000501	0.000584	CcSEcCtD
Nafarelin—Vomiting—Triamcinolone—atopic dermatitis	0.000496	0.000579	CcSEcCtD
Nafarelin—Vomiting—Methylprednisolone—atopic dermatitis	0.000495	0.000577	CcSEcCtD
Nafarelin—Nausea—Hydrocortisone—atopic dermatitis	0.000492	0.000574	CcSEcCtD
Nafarelin—Rash—Triamcinolone—atopic dermatitis	0.000492	0.000574	CcSEcCtD
Nafarelin—Dermatitis—Triamcinolone—atopic dermatitis	0.000491	0.000573	CcSEcCtD
Nafarelin—Rash—Methylprednisolone—atopic dermatitis	0.000491	0.000573	CcSEcCtD
Nafarelin—Dermatitis—Methylprednisolone—atopic dermatitis	0.00049	0.000572	CcSEcCtD
Nafarelin—Urticaria—Prednisone—atopic dermatitis	0.00049	0.000571	CcSEcCtD
Nafarelin—Headache—Triamcinolone—atopic dermatitis	0.000489	0.00057	CcSEcCtD
Nafarelin—Headache—Methylprednisolone—atopic dermatitis	0.000488	0.000569	CcSEcCtD
Nafarelin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000484	0.000565	CcSEcCtD
Nafarelin—Diarrhoea—Betamethasone—atopic dermatitis	0.000484	0.000565	CcSEcCtD
Nafarelin—Dizziness—Betamethasone—atopic dermatitis	0.000468	0.000546	CcSEcCtD
Nafarelin—Dizziness—Dexamethasone—atopic dermatitis	0.000468	0.000546	CcSEcCtD
Nafarelin—Nausea—Triamcinolone—atopic dermatitis	0.000463	0.000541	CcSEcCtD
Nafarelin—Nausea—Methylprednisolone—atopic dermatitis	0.000462	0.000539	CcSEcCtD
Nafarelin—Vomiting—Dexamethasone—atopic dermatitis	0.00045	0.000525	CcSEcCtD
Nafarelin—Vomiting—Betamethasone—atopic dermatitis	0.00045	0.000525	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CXCL10—atopic dermatitis	0.000448	0.00313	CbGpPWpGaD
Nafarelin—Rash—Dexamethasone—atopic dermatitis	0.000446	0.000521	CcSEcCtD
Nafarelin—Rash—Betamethasone—atopic dermatitis	0.000446	0.000521	CcSEcCtD
Nafarelin—Dermatitis—Betamethasone—atopic dermatitis	0.000446	0.00052	CcSEcCtD
Nafarelin—Dermatitis—Dexamethasone—atopic dermatitis	0.000446	0.00052	CcSEcCtD
Nafarelin—Headache—Dexamethasone—atopic dermatitis	0.000443	0.000517	CcSEcCtD
Nafarelin—Headache—Betamethasone—atopic dermatitis	0.000443	0.000517	CcSEcCtD
Nafarelin—Asthenia—Prednisone—atopic dermatitis	0.000442	0.000516	CcSEcCtD
Nafarelin—Pruritus—Prednisone—atopic dermatitis	0.000436	0.000509	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—atopic dermatitis	0.000422	0.000492	CcSEcCtD
Nafarelin—Nausea—Dexamethasone—atopic dermatitis	0.00042	0.000491	CcSEcCtD
Nafarelin—Nausea—Betamethasone—atopic dermatitis	0.00042	0.000491	CcSEcCtD
Nafarelin—Dizziness—Prednisone—atopic dermatitis	0.000408	0.000476	CcSEcCtD
Nafarelin—Vomiting—Prednisone—atopic dermatitis	0.000392	0.000457	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000391	0.00273	CbGpPWpGaD
Nafarelin—Rash—Prednisone—atopic dermatitis	0.000389	0.000454	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—atopic dermatitis	0.000388	0.000453	CcSEcCtD
Nafarelin—Headache—Prednisone—atopic dermatitis	0.000386	0.000451	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL5—atopic dermatitis	0.000385	0.00269	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2—atopic dermatitis	0.000374	0.00261	CbGpPWpGaD
Nafarelin—Nausea—Prednisone—atopic dermatitis	0.000366	0.000427	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NGF—atopic dermatitis	0.000357	0.00249	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000355	0.00248	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR5—atopic dermatitis	0.000347	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2—atopic dermatitis	0.00034	0.00237	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000294	0.00206	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL8—atopic dermatitis	0.00021	0.00147	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2—atopic dermatitis	0.000201	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—atopic dermatitis	0.0002	0.00139	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAPK8—atopic dermatitis	0.000185	0.00129	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—atopic dermatitis	0.000118	0.000824	CbGpPWpGaD
